INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine

Rhea-AI Summary

INOVIO's CEO, Dr. Jacqueline Shea, will participate in The Novel Therapeutics Forum hosted by Citizens JMP to discuss innovative technologies for treating and preventing diseases.

PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine at 10:00 am ET on April 2, 2024.

Dr. Shea will provide a brief overview of INOVIO and then participate in a panel discussion entitled "Innovative Technologies for Treating and Preventing Disease," which will be moderated by Roy Buchanan, biotechnology analyst at Citizens JMP.

The Citizens JMP Novel Therapeutics Forum will take place at the Jordan Medical Education Center at the Perelman Center for Advanced Medicine but will not be webcast.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

View original content:https://www.prnewswire.com/news-releases/inovio-to-participate-in-the-citizens-jmp-novel-therapeutics-forum-at-penn-medicine-302100288.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will Dr. Jacqueline Shea participate in The Novel Therapeutics Forum?

Dr. Jacqueline Shea will participate in The Novel Therapeutics Forum on April 2, 2024, at 10:00 am ET.

What is the focus of INOVIO as a biotechnology company?

INOVIO is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases.

Who will moderate the panel discussion at The Novel Therapeutics Forum?

The panel discussion at The Novel Therapeutics Forum will be moderated by Roy Buchanan, a biotechnology analyst at Citizens JMP.

Where will The Citizens JMP Novel Therapeutics Forum take place?

The Citizens JMP Novel Therapeutics Forum will take place at the Jordan Medical Education Center at the Perelman Center for Advanced Medicine.

Will the forum be webcasted?

No, the forum will not be webcasted.